regional prescription drugs markets. The global prescription drugs market is analyzed by revenues in US$ Billion. The global market is analyzed further by the following therapeutic classes/ categories - Oncologics/ Cancer Drugs, Lipid Regulators, Respiratory Agents, Proton Pump Inhibitors, Antidiabetics, Antipsychotics, Antidepressants, Angiotensin II Antagonists, Anti-Epileptics, Autoimmune Agents, and Others. Major regional markets analyzed in the report include USA, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Analytics for the period 2006-2015 provide a comprehensive understanding of the market. Additionally, historic review is provided for the period 2001 to 2005.
Global players profiled in the report include Pfizer, Glaxosmithkline, Novartis, Sanofi-Aventis, Astrazeneca, Roche, Johnson & Johnson, Merck & Co., Abbott, Eli Lilly, Amgen, Wyeth, Teva, Bayer, Takeda, and others. The study enumerates recent developments, mergers, acquisitions, and other strategic industry activities, and is an easy guide to What, Why, When, How, Where, and Who of the industry.
For more details about this comprehensive market research report, please visit - http://www.strategyr.com/Prescription_Drugs_Market_Report.asp
About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a reputed publisher of off-the-shelf market research. Founded in 1987, the company is globally recognized as one of the world's largest market research publishers. The company employs over 800 people worldwide and publishes more than 1100 full-scale research reports each year. Additionally, the company also offers thousands of smaller research products including company reports, marke
'/>"/>
Source: PRWeb Copyright©2009 Vocus, Inc. All rights reserved | |
Page: 1 2 3 4 Related biology technology :1.
Cell Therapeutics Added to Russell 3000(R), Russell 2000(R) and Russell Global(R) Indexes2.
BioStorage Technologies, Inc., Appoints Jeff Goddard to Global Head of Sales3.
Mylan Announces Strategic Collaboration with Biocon to Enter the Global Generic Biologics Market4.
deCODE Reinstated to Nasdaq Global Market5.
BIO Ventures for Global Health Announces Management Changes6.
World Nanomedicine Market to Cross $160 Billion by 2015, According to New Report by Global Industry Analysts, Inc.7.
Galichia Heart Hospital Partners with Mobile Surgery International to Develop Wichita-based Center of Excellence with Global Convenience(TM)8.
Sugarcane as a Key Element Against Global Warming to be Highlighted at Green Week in Brussels9.
BD and FIND Achieve Milestone in Global Battle Against MDR-TB10.
Springborn Deploys eStudy(TM) Hosted Solution for Management of Global Environmental Testing11.
Cell Therapeutics on Preliminary List of Additions to Russell 3000(R) Index and Russell Global(R) Index